ANDREW GUGGENHIME Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for ANDREW GUGGENHIME.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of ANDREW GUGGENHIME. ANDREW GUGGENHIME is SVP & Chief Financial Officer in PDL BIOPHARMA, INC. ($PDLI) and SVP & CFO in ABBOTT BIOTHERAPEUTICS CORP ($FACT).
Latest Insider Trading Transactions of ANDREW GUGGENHIME
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Option Exercise | A | 9.95 | 45,760 | 455,312 | 45,760 | |
| Aug 10 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Grant | A | 0.00 | 15,251 | 0 | 45,989 | 30.7 K to 46 K (+49.62 %) |
| Apr 06 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Option Exercise | A | 9.55 | 20,980 | 200,359 | 20,980 | |
| Apr 06 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Sell | D | 9.79 | 1,478 | 14,470 | 30,738 | 32.2 K to 30.7 K (-4.59 %) |
| Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Option Exercise | A | 6.17 | 64,000 | 394,880 | 64,000 | |
| Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Grant | A | 0.00 | 21,330 | 0 | 32,216 | 10.9 K to 32.2 K (+195.94 %) |
| Jan 27 2009 | FACT | ABBOTT BIOTHERAPEU ... | GUGGENHIME ANDREW | SVP & CFO | Grant | A | 0.00 | 8,270 | 0 | 10,886 | 2.6 K to 10.9 K (+316.13 %) |
| Dec 19 2008 | PDLI | PDL BIOPHARMA, INC ... | GUGGENHIME ANDREW | SVP & Chief Financi ... | Payment of Exercise | F | 0.00 | 3,575 | 0 | 13,255 | 16.8 K to 13.3 K (-21.24 %) |
| Jun 23 2008 | PDLI | PDL BIOPHARMA, INC ... | GUGGENHIME ANDREW | SVP & Chief Financi ... | Grant | A | 0.00 | 10,000 | 0 | 16,830 | 6.8 K to 16.8 K (+146.41 %) |
Page: 1